NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
NAMS Stock Analysis: Buy, Sell, or Hold?
$19.18
+0.18 (+0.95%)
▲
5d:
-3.62%
30d:
-9.74%
90d:
-31.08%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect NAMS Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$19.50 – $21.79
Position: OVERSOLD
Forward P/E & Valuation
-12.5x
Next 12M consensus est.
Wall Street Target
$50.44
+163.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$17.90 / $22.26
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NAMS shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 6, 2026 at $18.98 · last confirmed Nov 6, 2026
Strength: 4.6/10
Get Alerted When NAMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NAMS is currently trading at $19.18, which is considered oversold relative to its 30-day fair value range of $19.50 to $21.79.
Technical Outlook: Technically, NAMS is in a strong downtrend. Immediate support is located at $17.90, while resistance sits at $22.26.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $50.44 (+163.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NAMS is in a strong downtrend. Immediate support is located at $17.90, while resistance sits at $22.26.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $50.44 (+163.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.50 -
$21.79
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$19.50 -
$21.79
Current vs Trading Range
OVERSOLD
Support Level
$17.90
Resistance Level
$22.26
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding NAMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 163.0% below Wall St target ($50.44)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-12.49
Wall Street Target
$50.44
(+163.0%)
Revenue Growth (YoY)
5406.9%
Share NAMS Analysis
Share this live NAMS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NAMS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 19, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment prevails on StockTwits for $NAMS with no recent news articles available.
Key Retail Themes:
Positive outlook for New Ams Pharma
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 AM ET
Data refreshes hourly during market hours. Next update: 9:58 AM
Data refreshes hourly during market hours. Next update: 9:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 43 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
Advanced NAMS Option Strategies
Professional options setups generated by AI based on today's NAMS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NAMS Research Pages
